PAHC

PHIBRO ANIMAL HEALTH CORP · Healthcare · Market cap $1.6B

Insiders bought $318K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Jun 2, 2026

Insider Buying

$318K

reported purchases (SEC code P)

Insider Selling

$32.0M

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Latest filing

Aug 10, 2026

CORCORAN E THOMAS

PHIBRO ANIMAL HEALTH CORP (PAHC) has 52 SEC Form 4 filings (151 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 10, 2026.

Inside the rolling window, 2 insiders at PHIBRO ANIMAL HEALTH CORP reported 1 open-market purchase totaling $318K and 74 open-market sales totaling $32.0M. The most active filer is President and CEO BENDHEIM JACK with 74 filings. Insiders have net sold $13.9M over the trailing 6 months. The most recent open-market filing is a purchase of 10,000 shares by Director CORCORAN E THOMAS, dated May 29, 2026, worth $318K.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Jack Clifford Bendheim
  • Employees:2,475
  • HQ:Teaneck, NJ, US
  • IPO:2014-04-11
Source
CORCORAN E THOMASFirst filing
Purchase$318KJun 2SEC ↗
Sale$393KMay 7SEC ↗
Sale$404KMay 7SEC ↗
Sale$220KMay 7SEC ↗
Sale$394KApr 30SEC ↗
Sale$373KApr 30SEC ↗
Sale$371KApr 30SEC ↗
Sale$394KApr 23SEC ↗
Sale$382KApr 23SEC ↗
Sale$381KApr 23SEC ↗
Sale$416KApr 16SEC ↗
Sale$401KApr 16SEC ↗
Sale$385KApr 16SEC ↗
Sale$377KMar 31SEC ↗
Sale$379KMar 31SEC ↗
Sale$373KMar 26SEC ↗
Sale$394KMar 26SEC ↗
Sale$400KMar 26SEC ↗
Sale$273KMar 19SEC ↗
Sale$556KMar 19SEC ↗
Sale$370KMar 19SEC ↗
Sale$258KMar 16SEC ↗
Sale$362KFeb 26SEC ↗
Sale$364KFeb 26SEC ↗
Sale$378KFeb 26SEC ↗
Showing 1–25 of 75
1 / 3

Congress trading PAHC 11 all-time

  • RRep. Michael T. McCaulSale$1,001 - $15,0002022-09-01
  • RRep. Michael T. McCaulSale$1,001 - $15,0002022-09-01
  • RRep. Michael T. McCaulSale$1,001 - $15,0002022-08-30
  • RRep. Michael T. McCaulSale$1,001 - $15,0002022-08-30
  • RRep. Michael T. McCaulSale$1,001 - $15,0002022-03-02
  • RRep. Michael T. McCaulSale$1,001 - $15,0002022-03-04

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does PAHC have?

PHIBRO ANIMAL HEALTH CORP (PAHC) has 52 SEC Form 4 filings (151 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Aug 10, 2026.

When was the most recent SEC Form 4 filing for PAHC?

The most recent Form 4 filing for PAHC on Tracefour is dated Aug 10, 2026.

Who is the most active insider at PAHC?

The most active SEC Form 4 filer at PAHC in the rolling window is President and CEO BENDHEIM JACK, with 74 filings.

What is the net insider flow at PAHC over the last 6 months?

Over the trailing 180 days, insiders at PAHC have net sold $13.9M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at PAHC in the current window?

Inside the rolling window, insiders at PAHC bought $318K and sold $32.0M based on SEC Form 4 filings.

Can I get alerts for PAHC insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PHIBRO ANIMAL HEALTH CORP (PAHC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

PHIBRO ANIMAL HEALTH CORP is in the Healthcare sector.